Evidence reviews - June 2026
The following documents contain the evidence that was used to develop the 2026 recommendations:
- Platinum-containing chemotherapy regimens
- FDG PET-CT and contrast-enhanced CT for diagnosing and monitoring distant metastases
Other supporting evidence
Full guideline
This page was last updated: